Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections

Summary: Introduction: Escherichia coli producing extended spectrum-β-lactamases (ESBL), particularly CTX-M type ESBLs, have rapidly spread worldwide and pose a serious threat for healthcare-associated infections. We performed a molecular detection and characterization study of ESBL-related bla gen...

Full description

Bibliographic Details
Main Authors: Arindam Chakraborty, Prabha Adhikari, Shalini Shenoy, Vishwas Saralaya
Format: Article
Language:English
Published: Elsevier 2015-05-01
Series:Journal of Infection and Public Health
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034114001543
_version_ 1811333408875347968
author Arindam Chakraborty
Prabha Adhikari
Shalini Shenoy
Vishwas Saralaya
author_facet Arindam Chakraborty
Prabha Adhikari
Shalini Shenoy
Vishwas Saralaya
author_sort Arindam Chakraborty
collection DOAJ
description Summary: Introduction: Escherichia coli producing extended spectrum-β-lactamases (ESBL), particularly CTX-M type ESBLs, have rapidly spread worldwide and pose a serious threat for healthcare-associated infections. We performed a molecular detection and characterization study of ESBL-related bla genes, including blaTEM, blaSHV, blaCTX-M, and blaCTX-M15, and also assessed the relationship between the phylogenetic background of strains carrying ESBL genes and the patient's clinical outcome. Methodology: A total of 300 non-repeated, clinically significant isolates were investigated. The molecular types of ESBL genes were determined using multiplex PCR. Phylogenetic analysis was performed using triplex PCR methods. Antibiograms and the patient's clinical outcome were collected in a structured pro forma. Results: Among the 300 isolates, 212 (70.5%) isolates were found to carry ESBL genes. A total of 186 (62%) strains were positive for the blaCTX-M gene, and 171 isolates (approximately 92%) of these blaCTX-M producers were positive for blaCTXM-15. Phylogenetic analysis of the isolates indicated that 41 (67%) Group A, 22 (81.50%) group B1, 67 (64.5%) group B2 and 82 (76%) group D isolates carried different ESBL genes. Appropriate antibiotic therapy helped to resolve infection in 66.5% patients. Conclusion: Our study documented the high prevalence of ESBLs in E. coli isolates, with CTX-M-15 as the predominant ESBL gene in the region, and these isolates predominantly belonged to commensal phylo-groups. Thus, an appropriate antibiotic and hospital policy is required to reduce the horizontal spread of ESBL genes among various bacterial strains, whereas in the near future, the spread of ESBL producers may result in therapeutic dead ends. Keywords: E. coli, ESBL, CTXM15, Phylogroup, Outcome
first_indexed 2024-04-13T16:52:08Z
format Article
id doaj.art-8b86251debe94ca9b07597efecfb21a3
institution Directory Open Access Journal
issn 1876-0341
language English
last_indexed 2024-04-13T16:52:08Z
publishDate 2015-05-01
publisher Elsevier
record_format Article
series Journal of Infection and Public Health
spelling doaj.art-8b86251debe94ca9b07597efecfb21a32022-12-22T02:38:55ZengElsevierJournal of Infection and Public Health1876-03412015-05-0183248253Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infectionsArindam Chakraborty0Prabha Adhikari1Shalini Shenoy2Vishwas Saralaya3Department of Microbiology, Government Medical College, Ambedkar Nagar, Uttar Pradesh 224122, India; Corresponding author. Tel.: +91 7408881369.Department of Medicine, Kasturba Medical College, Mangalore, Manipal University, Karnataka 575001, IndiaDepartment of Microbiology, Kasturba Medical College, Mangalore, Manipal University, Karnataka 575001, IndiaDepartment of Microbiology, Kasturba Medical College, Mangalore, Manipal University, Karnataka 575001, IndiaSummary: Introduction: Escherichia coli producing extended spectrum-β-lactamases (ESBL), particularly CTX-M type ESBLs, have rapidly spread worldwide and pose a serious threat for healthcare-associated infections. We performed a molecular detection and characterization study of ESBL-related bla genes, including blaTEM, blaSHV, blaCTX-M, and blaCTX-M15, and also assessed the relationship between the phylogenetic background of strains carrying ESBL genes and the patient's clinical outcome. Methodology: A total of 300 non-repeated, clinically significant isolates were investigated. The molecular types of ESBL genes were determined using multiplex PCR. Phylogenetic analysis was performed using triplex PCR methods. Antibiograms and the patient's clinical outcome were collected in a structured pro forma. Results: Among the 300 isolates, 212 (70.5%) isolates were found to carry ESBL genes. A total of 186 (62%) strains were positive for the blaCTX-M gene, and 171 isolates (approximately 92%) of these blaCTX-M producers were positive for blaCTXM-15. Phylogenetic analysis of the isolates indicated that 41 (67%) Group A, 22 (81.50%) group B1, 67 (64.5%) group B2 and 82 (76%) group D isolates carried different ESBL genes. Appropriate antibiotic therapy helped to resolve infection in 66.5% patients. Conclusion: Our study documented the high prevalence of ESBLs in E. coli isolates, with CTX-M-15 as the predominant ESBL gene in the region, and these isolates predominantly belonged to commensal phylo-groups. Thus, an appropriate antibiotic and hospital policy is required to reduce the horizontal spread of ESBL genes among various bacterial strains, whereas in the near future, the spread of ESBL producers may result in therapeutic dead ends. Keywords: E. coli, ESBL, CTXM15, Phylogroup, Outcomehttp://www.sciencedirect.com/science/article/pii/S1876034114001543
spellingShingle Arindam Chakraborty
Prabha Adhikari
Shalini Shenoy
Vishwas Saralaya
Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections
Journal of Infection and Public Health
title Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections
title_full Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections
title_fullStr Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections
title_full_unstemmed Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections
title_short Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections
title_sort clinical significance and phylogenetic background of extended spectrum β lactamase producing escherichia coli isolates from extra intestinal infections
url http://www.sciencedirect.com/science/article/pii/S1876034114001543
work_keys_str_mv AT arindamchakraborty clinicalsignificanceandphylogeneticbackgroundofextendedspectrumblactamaseproducingescherichiacoliisolatesfromextraintestinalinfections
AT prabhaadhikari clinicalsignificanceandphylogeneticbackgroundofextendedspectrumblactamaseproducingescherichiacoliisolatesfromextraintestinalinfections
AT shalinishenoy clinicalsignificanceandphylogeneticbackgroundofextendedspectrumblactamaseproducingescherichiacoliisolatesfromextraintestinalinfections
AT vishwassaralaya clinicalsignificanceandphylogeneticbackgroundofextendedspectrumblactamaseproducingescherichiacoliisolatesfromextraintestinalinfections